KBL697

DRUG3 trials

Sponsors

KoBioLabs

Conditions

Atopic Dermatitis (AD)Psoriatic PlaqueUlcerative Colitis

Phase 1

A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

CompletedNCT04056130

KoBioLabsAtopic Dermatitis (AD)

Start: 2019-10-04End: 2020-01-07Updated: 2021-09-08

Phase 2

A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

WithdrawnNCT04898348

KoBioLabsUlcerative Colitis

Start: 2022-01-14End: 2023-07-28Updated: 2023-08-02

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

CompletedNCT04911751

KoBioLabsPsoriatic Plaque

Start: 2021-11-08End: 2024-10-07Updated: 2025-01-07